← Back
$BBIO All transactions

BridgeBio Pharma, Inc.

▼ SELL 10b5-1 Plan

$ Value

$395K

Shares

5,300

Price

$75

Filed

Apr 13

Insider

Name

Kumar Neil

Title

Chief Executive Officer

CIK

0001742485

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-09

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

623,186

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025. | Represents the weighted average sale price of the shares sold from $73.19 to $74.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. | Represents the weighted average sale price of the shares sold from $74.19 to $75.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $75.22 to $76.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $73.15 to $74.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $74.18 to $75.145 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $75.18 to $76.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $74.26 to $75.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. | Represents the weighted average sale price of the shares sold from $74.27 to $75.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Filing Info

Accession No.

0001470831-26-000361

Form Type

4

Issuer CIK

0001743881

Kumar Neil's History

Date Ticker Type Value
2026-04-10 BBIO $1.5M
2026-04-10 BBIO $1.5M
2026-04-09 BBIO $530K
2026-04-09 BBIO $395K
2026-04-09 BBIO $567K
2026-04-09 BBIO $521K
2026-04-09 BBIO $382K
2026-04-09 BBIO $589K
2026-03-27 MAZE A $0
2025-09-05 BBIO $119K

Other Insiders at BBIO (90d)

Insider Bought Sold Last
Kumar Neil
Chief Executive Officer
$5.6M 2026-04-10